Although bortezomib has been a breakthrough in cancer treatment, resistance can still develop. Mechanisms of resistance include changes in proteasome subunits, increased expression of anti-apoptotic proteins, and alterations in cellular stress responses. Ongoing research is focused on understanding these mechanisms and developing strategies to overcome resistance, such as combining bortezomib with other targeted therapies.
